Table 2.
Influence of chronic hepatitis B virus infection on acute hepatitis E n (%)
|
HBV + HEV group |
|||||||||
|
Status of HBeAg |
Status of HBV DNA |
Status of cirrhosis |
|||||||
| + (n = 20) | - (n = 98) | P value | + (n = 65) | - (n = 53) | P value | + (n = 17) | - (n = 101) | P value | |
| MELD score | 17.0 ± 7.0 | 20.6 ± 10.1 | 0.131 | 21.5 ± 10.6 | 18.3 ± 8.3 | 0.074 | 24.7 ± 12.2 | 19.2 ± 9.1 | 0.031 |
| Liver failure | 5 (25) | 37 (37.8) | 0.317 | 25 (38.5) | 17 (32.1) | 0.563 | 11 (64.7) | 31 (30.7) | 0.011 |
| Complications | 7 (35) | 40 (40.8) | 0.803 | 25 (38.5) | 22 (41.5) | 0.850 | 16 (94.1) | 31 (30.7) | 0.001 |
| Death | 2 (10) | 22 (22.4) | 0.359 | 14 (21.5) | 10 (19.9) | 0.820 | 4 (23.5) | 20 (19.8) | 0.748 |
1
Denotes significant P value. HBV: Hepatitis B virus; HEV: Hepatitis E virus; HBeAg: Hepatitis B e antigen; MELD: Model for End-Stage Liver Disease.